NewsBite

Carnage continues for health stocks in the wake of MYEFO cuts

Primary Health Care chief executive Peter Gregg has signalled he will pass government funding cuts for blood tests and X-rays onto patients after the policy change sparked a rout in healthcare stocks.

In Tuesday's Mid-Year Economic and Fiscal Outlook the government said it would save $650.4 million over four years by slashing bulk-billing incentive payments for certain pathology and imaging tests such as MRIs, X-rays, and urine and blood tests.

Loading...
Tim Binsted writes on Business specialising in Agriculture, Construction, Manufacturing. Tim is based in our Sydney newsroom. Connect with Tim on Twitter.

Read More

Latest In Equity markets

Fetching latest articles

Most Viewed In Markets

    Original URL: https://www.afr.com/business/health/carnage-continues-for-health-stocks-in-the-wake-of-myefo-cuts-20151215-glok0j